Seelos Therapeutics Inc
NASDAQ:SEEL
Seelos Therapeutics Inc
Total Other Income
Seelos Therapeutics Inc
Total Other Income Peer Comparison
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Seelos Therapeutics Inc
NASDAQ:SEEL
|
Total Other Income
$11.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Total Other Income
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Total Other Income
-$149m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-54%
|
|
Pfizer Inc
NYSE:PFE
|
Total Other Income
-$5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
50%
|
CAGR 10-Years
N/A
|
|
Merck & Co Inc
NYSE:MRK
|
Total Other Income
$1.5B
|
CAGR 3-Years
48%
|
CAGR 5-Years
41%
|
CAGR 10-Years
18%
|
|
Eli Lilly and Co
NYSE:LLY
|
Total Other Income
$456.1m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
3%
|
CAGR 10-Years
20%
|
See Also
What is Seelos Therapeutics Inc's Total Other Income?
Total Other Income
11.6m
USD
Based on the financial report for Dec 31, 2023, Seelos Therapeutics Inc's Total Other Income amounts to 11.6m USD.